# Emily Rich

> Emily Rich is a seed investor at M8 Ventures backing SaaS, Medical and Software. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [M8 Ventures](https://shizune.co/investors/profile/m8-ventures)
- Total investments: 4
- Last investment: Apr 2025
- Lead investor: 25%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/emily-rich-9a24b972/

Emily Rich is a Partner of M8 Ventures and Director of Startups of Microsoft.Emily is an awarded innovator having won the 2015 Startup Adelaide Startup of the Year Award, Newscorp Women in Innovation Award (Technology) and winner of Young IT Professional of the Year 2015 (ACS, National). With a base degree in Information Technology, Networkingand Security, Emily has extensive IT and business experience and is passionate about finding technology solutions to benefit the world.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| SaaS | 1 | 25% |
| Medical | 1 | 25% |
| Software | 1 | 25% |
| Marketing | 1 | 25% |
| Advertising | 1 | 25% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 50% |
| Pre-Seed | 1 | 25% |
| Series A | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Hola Health | At Hola, we’re creating the future of healthcare. Connecting patients, practitioners and pharmacies to deliver more timely & convenient access to care that we call ‘on-demand healthcare’. | $3.6M | Series A | Apr 08, 2025 |  |
| Flowing Bee | Flowing Bee is a trailblazing SaaS startup revolutionising the way businesses understand and engage with their audiences. By blending cutting-edge AI with the principles of behavioural science, we empower marketing teams to unlock deep psychological insights and craft campaigns that drive real, measurable results.The Flowing Bee platformenables businesses to conduct behavioural studies, uncovering the “why” behind consumer decisions. From optimising marketing comms, to designing high-impact strategies, we help our clients stretch their marketing budgets and achieve their goals with precision and creativity.In the short time Flowing Bee has been operating, we have secured investment from some of Australia’s largest and most reputable VC firms, and have brought on ASX-listed customers across the retail, healthcare and financial services sectors | $1M | Pre-Seed | Feb 05, 2025 |  |
| Xylo Bio | Xylo Bio is a drug development company that focuses on next-generation psychedelics. With psychedelic molecules as the starting point, our goal is to develop medicines that are widely available as improved treatments to currently available SSRI medications. | $8M | Seed | Jun 02, 2024 |  |
| Hola Health | At Hola, we’re creating the future of healthcare. Connecting patients, practitioners and pharmacies to deliver more timely & convenient access to care that we call ‘on-demand healthcare’. | $2.9M | Seed | Mar 19, 2024 |  |

4 of 4 investments shown.

## Co-investors
- [Archangel Ventures](https://shizune.co/investors/profile/archangel-ventures) — VC Fund, 2 deals together
- [Fund WA](https://shizune.co/investors/profile/fund-wa) — VC Fund, 2 deals together
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund, 1 deal together
- [Empath Ventures](https://shizune.co/investors/profile/empath-ventures) — VC Fund, 1 deal together
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund, 1 deal together
- [Genesis Pre-Seed Fund](https://shizune.co/investors/profile/genesis-pre-seed-fund) — VC Fund, 1 deal together

## About M8 Ventures

VC Fund · Sydney, Australia

M8 Ventures is a small, fast, pre-seed specialist venture fund focusing on the earliest stages of investment in the next generation of successful global tech companies from Australia and New Zealand. The firm was founded in 2018 and based in Sydney, New South Wales, Australia.

2 contacts available at M8 Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Emily Rich | Partner | https://shizune.co/investors/profile/emily-rich |
| Alan Jones | General Partner | https://shizune.co/investors/profile/alan-jones |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Emily Rich invest in?

Emily Rich invests primarily in SaaS, Medical and Software startups, most often at Seed and Pre-Seed stage. Most of the 4 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Emily Rich last invest?

The most recent investment recorded for Emily Rich closed in Apr 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co